Techub News: The board of directors of Anixa Biosciences (NASDAQ: ANIX), a publicly traded company in the United States, has approved the purchase of Bitcoin as a treasury reserve asset, aiming to diversify the company's assets while allowing Anixa to benefit from the potential long-term value of digital assets. Anixa is a clinical-stage biotechnology company focused on cancer treatment and prevention.